These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia. Currow DC; Skipworth RJ Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564 [TBL] [Abstract][Full Text] [Related]
24. Mirtazapine in Cancer-Associated Anorexia and Cachexia: A Double-Blind Placebo-Controlled Randomized Trial. Hunter CN; Abdel-Aal HH; Elsherief WA; Farag DE; Riad NM; Alsirafy SA J Pain Symptom Manage; 2021 Dec; 62(6):1207-1215. PubMed ID: 34051293 [TBL] [Abstract][Full Text] [Related]
25. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587 [TBL] [Abstract][Full Text] [Related]
26. Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome--a systematic review and meta-analysis. Leśniak W; Bała M; Jaeschke R; Krzakowski M Pol Arch Med Wewn; 2008 Nov; 118(11):636-44. PubMed ID: 19140567 [TBL] [Abstract][Full Text] [Related]
27. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Bar-Sela G; Zalman D; Semenysty V; Ballan E Integr Cancer Ther; 2019; 18():1534735419881498. PubMed ID: 31595793 [No Abstract] [Full Text] [Related]
28. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Berenstein EG; Ortiz Z Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706 [TBL] [Abstract][Full Text] [Related]
29. Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Mantovani G; Madeddu C; Macciò A; Gramignano G; Lusso MR; Massa E; Astara G; Serpe R Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1651-9. PubMed ID: 15466983 [TBL] [Abstract][Full Text] [Related]
30. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. Goldberg RM; Loprinzi CL; Mailliard JA; O'Fallon JR; Krook JE; Ghosh C; Hestorff RD; Chong SF; Reuter NF; Shanahan TG J Clin Oncol; 1995 Nov; 13(11):2856-9. PubMed ID: 7595749 [TBL] [Abstract][Full Text] [Related]
31. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. Del Fabbro E; Dev R; Hui D; Palmer L; Bruera E J Clin Oncol; 2013 Apr; 31(10):1271-6. PubMed ID: 23439759 [TBL] [Abstract][Full Text] [Related]
32. [The Treatment of Cancer Cachexia]. Tanaka S; Takayama K Gan To Kagaku Ryoho; 2021 Aug; 48(8):987-991. PubMed ID: 34404062 [TBL] [Abstract][Full Text] [Related]
33. The abridged patient-generated subjective global assessment is a useful tool for early detection and characterization of cancer cachexia. Vigano AL; di Tomasso J; Kilgour RD; Trutschnigg B; Lucar E; Morais JA; Borod M J Acad Nutr Diet; 2014 Jul; 114(7):1088-1098. PubMed ID: 24462323 [TBL] [Abstract][Full Text] [Related]
34. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631 [TBL] [Abstract][Full Text] [Related]
35. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Madeddu C; Dessì M; Panzone F; Serpe R; Antoni G; Cau MC; Montaldo L; Mela Q; Mura M; Astara G; Tanca FM; Macciò A; Mantovani G Clin Nutr; 2012 Apr; 31(2):176-82. PubMed ID: 22047681 [TBL] [Abstract][Full Text] [Related]
36. Modern management of the cancer anorexia-cachexia syndrome. Nelson KA Curr Pain Headache Rep; 2001 Jun; 5(3):250-6. PubMed ID: 11309213 [TBL] [Abstract][Full Text] [Related]
37. Is the pharmacological treatment of cancer cachexia possible? Bruera E Support Care Cancer; 1993 Nov; 1(6):298-304. PubMed ID: 8156247 [TBL] [Abstract][Full Text] [Related]
38. IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment. Chowdhury IH; Rahman S; Afroze YJ; Shovah ST Pharmacol Res; 2024 May; 203():107129. PubMed ID: 38461961 [TBL] [Abstract][Full Text] [Related]
39. Re-validation and shortening of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire. Ribaudo JM; Cella D; Hahn EA; Lloyd SR; Tchekmedyian NS; Von Roenn J; Leslie WT Qual Life Res; 2000; 9(10):1137-46. PubMed ID: 11401046 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. Akamizu T; Kangawa K Peptides; 2011 Nov; 32(11):2295-300. PubMed ID: 21635929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]